475 related articles for article (PubMed ID: 30968687)
1. Amphiphilic Gemini Iridium(III) Complex as a Mitochondria-Targeted Theranostic Agent for Tumor Imaging and Photodynamic Therapy.
Yi S; Lu Z; Zhang J; Wang J; Xie Z; Hou L
ACS Appl Mater Interfaces; 2019 May; 11(17):15276-15289. PubMed ID: 30968687
[TBL] [Abstract][Full Text] [Related]
2. Neutral iridium(iii) complexes bearing BODIPY-substituted N-heterocyclic carbene (NHC) ligands: synthesis, photophysics, in vitro theranostic photodynamic therapy, and antimicrobial activity.
Liu B; Monro S; Jabed MA; Cameron CG; Colón KL; Xu W; Kilina S; McFarland SA; Sun W
Photochem Photobiol Sci; 2019 Oct; 18(10):2381-2396. PubMed ID: 31432864
[TBL] [Abstract][Full Text] [Related]
3. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916
[TBL] [Abstract][Full Text] [Related]
4. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
[TBL] [Abstract][Full Text] [Related]
5. Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents.
Wang L; Yin H; Cui P; Hetu M; Wang C; Monro S; Schaller RD; Cameron CG; Liu B; Kilina S; McFarland SA; Sun W
Dalton Trans; 2017 Jun; 46(25):8091-8103. PubMed ID: 28604869
[TBL] [Abstract][Full Text] [Related]
6. A Cyclometalated Ir
Sudheesh KV; Jayaram PS; Samanta A; Bejoymohandas KS; Jayasree RS; Ajayaghosh A
Chemistry; 2018 Aug; 24(43):10999-11007. PubMed ID: 29806867
[TBL] [Abstract][Full Text] [Related]
7. A Mitochondria-Targeted Photosensitizer Showing Improved Photodynamic Therapy Effects Under Hypoxia.
Lv W; Zhang Z; Zhang KY; Yang H; Liu S; Xu A; Guo S; Zhao Q; Huang W
Angew Chem Int Ed Engl; 2016 Aug; 55(34):9947-51. PubMed ID: 27381490
[TBL] [Abstract][Full Text] [Related]
8. Versatile Strategy To Generate a Rhodamine Triplet State as Mitochondria-Targeting Visible-Light Photosensitizers for Efficient Photodynamic Therapy.
Liu C; Zhou L; Wei F; Li L; Zhao S; Gong P; Cai L; Wong KM
ACS Appl Mater Interfaces; 2019 Mar; 11(9):8797-8806. PubMed ID: 30730131
[TBL] [Abstract][Full Text] [Related]
9. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
[TBL] [Abstract][Full Text] [Related]
10. Photophysical and Photobiological Properties of Dinuclear Iridium(III) Bis-tridentate Complexes.
Liu B; Monro S; Lystrom L; Cameron CG; Colón K; Yin H; Kilina S; McFarland SA; Sun W
Inorg Chem; 2018 Aug; 57(16):9859-9872. PubMed ID: 30091916
[TBL] [Abstract][Full Text] [Related]
11. Ligand Dictated Photosensitization of Iridium(III) Dithiocarbamate Complexes for Photodynamic Therapy.
Negi M; Dixit T; Venkatesh V
Inorg Chem; 2023 Dec; 62(49):20080-20095. PubMed ID: 37994001
[TBL] [Abstract][Full Text] [Related]
12. Rational Design of Phosphorescent Iridium(III) Complexes for Selective Glutathione Sensing and Amplified Photodynamic Therapy.
Huang T; Yu Q; Liu S; Zhang KY; Huang W; Zhao Q
Chembiochem; 2019 Feb; 20(4):576-586. PubMed ID: 30267457
[TBL] [Abstract][Full Text] [Related]
13. Exploring a Mitochondria Targeting, Dinuclear Cyclometalated Iridium (III) Complex for Image-Guided Photodynamic Therapy in Triple-Negative Breast Cancer Cells.
Neelambaran N; Shamjith S; Murali VP; Maiti KK; Joseph J
ACS Appl Bio Mater; 2023 Dec; 6(12):5776-5788. PubMed ID: 38061031
[TBL] [Abstract][Full Text] [Related]
14. Photostable Iridium(III)-Cyanine Complex Nanoparticles for Photoacoustic Imaging Guided Near-Infrared Photodynamic Therapy in Vivo.
Yang Q; Jin H; Gao Y; Lin J; Yang H; Yang S
ACS Appl Mater Interfaces; 2019 May; 11(17):15417-15425. PubMed ID: 30964627
[TBL] [Abstract][Full Text] [Related]
15. A self-assessed photosensitizer: inducing and dual-modal phosphorescence imaging of mitochondria oxidative stress.
Yang J; Cao Q; Hao L; Yang GG; Hu WL; Ji LN; Mao ZW
Chem Commun (Camb); 2018 Jan; 54(3):271-274. PubMed ID: 29231930
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-Targeting Polyamine-Protoporphyrin Conjugates for Photodynamic Therapy.
Taba F; Onoda A; Hasegawa U; Enoki T; Ooyama Y; Ohshita J; Hayashi T
ChemMedChem; 2018 Jan; 13(1):15-19. PubMed ID: 28961376
[TBL] [Abstract][Full Text] [Related]
17. Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy.
Taratula O; Schumann C; Duong T; Taylor KL; Taratula O
Nanoscale; 2015 Mar; 7(9):3888-902. PubMed ID: 25422147
[TBL] [Abstract][Full Text] [Related]
18. A biomimetic theranostic O
Li SY; Xie BR; Cheng H; Li CX; Zhang MK; Qiu WX; Liu WL; Wang XS; Zhang XZ
Biomaterials; 2018 Jan; 151():1-12. PubMed ID: 29040939
[TBL] [Abstract][Full Text] [Related]
19. Cyclometalated Ir(III) theranostic molecular probe enabled mitochondria targeted fluorescence-SERS-guided phototherapy in breast cancer cells.
Reghukumar C; Shamjith S; Murali VP; Ramya PK; Radhakrishnan KV; Maiti KK
J Photochem Photobiol B; 2024 Jan; 250():112832. PubMed ID: 38142588
[TBL] [Abstract][Full Text] [Related]
20. Nitroreductase-Activatable Theranostic Molecules with High PDT Efficiency under Mild Hypoxia Based on a TADF Fluorescein Derivative.
Liu Z; Song F; Shi W; Gurzadyan G; Yin H; Song B; Liang R; Peng X
ACS Appl Mater Interfaces; 2019 May; 11(17):15426-15435. PubMed ID: 30945838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
